Combined percutaneous carotid stenting and coronary angioplasty during acute ischemic neurologic and coronary syndromes

Current global status of carotid artery stent placement

“…Similarly, in the series of Shawl et al [14][15][16] of 87 patients, 75% of the symptomatic and 70% of the asymptomatic patients would reportedly have been excluded from the NASCET and ACAS entry criteria. Also, 63% of Dr. Shawl's patients underwent staged or at the same sitting coronary intervention because of class III or IV angina [14][15].…”

Benefits of Cerebral Protection during Carotid Stenting with the PercuSurge GuardWire System: Midterm Results

“…This study showed that protected CAS is a feasible and safe procedure with a very low 2.2% 30-day neurological complication rate, which is comparable to other studies of unprotected carotid stenting and historical surgical controls. 16,18,21,37,44,45 However, cerebral protection cannot prevent all embolic events that may occur at all steps in the procedure. The balloon protection device is active against embolism only after the wire has crossed the lesion; this maneuver and even the initial positioning of the guide catheter in the CCA can release embolic material.…”

Short- and long-term histopathologic evaluation of stenting using a self-expanding nitinol stent in pig carotid and iliac arteries

“…Carotid stenting for the adjunctive treatment of obstructive atherosclerotic carotid artery disease may be an alternative [9][10][11], even in unstable conditions [12]. A recent worldwide survey on carotid artery stenting revealed a periprocedural 1.32% rate of major strokes, a mortality rate of 1.37% at 1 month, and a restenosis rate of 4.8% at 6 months [13].…”